Navigation Links
ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent
Date:9/9/2008

rowXpress(TM) and

companion sterile blood processing disposable for harvesting stem cells

in a closed system. The AXP device is used for the processing of cord

blood. GE Healthcare is the exclusive global distribution partner for

the AXP cord blood product except for Central and South America, China

and Russia/CIS, where ThermoGenesis markets through independent

distributors. The MarrowXpress is used for isolating stem cells from

bone marrow. ThermoGenesis sells the MarrowXpress directly to global

customers.

-- The CryoSeal(R) FS System, an automated device and companion sterile

blood processing disposable, is used to prepare fibrin sealants from

plasma in about an hour. The CryoSeal FS System is approved in the

U.S. for liver resection surgeries. The CryoSeal FS System has

received the CE-Mark which allows sales of the product throughout the

European community. Asahi Medical is the exclusive distributor for the

CryoSeal System in Japan and the Company markets through independent

distributors in Europe and South America.

-- The Thrombin Processing Device(TM) (TPD(TM)) is a sterile blood

processing disposable that prepares activated thrombin from a small

aliquot of plasma in less than 30 minutes. The CE-Marked TPD is

currently being marketed in Europe by Biomet, Inc., subsidiary Biomet

Biologics, Medtronic, Inc. and independent distributors.

This press release contains forward-looking statements, and such statements

are made pursuant to the safe harbor provisions of the Private Securities

Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual outcomes to differ materially from those

contemplated by the forward-looking statements. Several factors, including

timing of FDA approvals, changes in custo
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
2. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
3. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
4. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
5. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
6. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
7. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
8. ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
9. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
10. ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
11. ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Spectrum Blue Steel is emerging as one of the ... efforts of True Green Energy Group and True Green Planet,s ... the recycling business for over 25 years, stated that Spectrum ... setting the stage for spectacular earnings because of the bi ...
(Date:12/2/2009)... 2 Reportlinker.com announces that a new ... catalogue: ,, Carbondioxide Incubators - A ... ,, Incubators are the most ... research, and other applications for providing a ...
(Date:12/2/2009)... research executives, scientists, policy makers, and funders today convened ... at the inaugural Partnering for Cures meeting. ... the Milken Institute, convened Partnering for Cures ... discovery into an accessible therapy. This effort unites ...
(Date:12/2/2009)... (Nasdaq: PPHM ) today reported completion of patient ... Cotara® in patients with relapsed glioblastoma multiforme (GBM), the ... targeted monoclonal antibody linked to a radioisotope being developed ... specifically targets cells at the center of brain tumors, ...
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
... an acceptable primary endpoint, for a ... 28 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: ... an agreement with the U.S. Food and Drug Administration ... registration trial of OGX-011, its lead product candidate targeting ...
... S.MAMEDE DO CORONADO, Portugal and LONDON, April 28 ... Treatment of Epilepsy Patients With Partial Onset,Seizures , ... do Coronado, Portugal, President &,CEO Dr Luis Portela), and ... European subsidiary of Eisai Co., Ltd. (Tokyo, President &,CEO: ...
... -- Encorium Group, Inc. (Nasdaq: ... organization (CRO) that provides design, development, and management ... many of the world,s leading pharmaceutical companies, today ... Second Annual Vaccine Industry Excellence Award for Best ...
Other Biology Technology:OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 2OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 3OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 4OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 5OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 6Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 2Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 3Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 4Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 5Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 6Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 7Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 8Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union 9Encorium Named as Finalist for the Second Annual Vaccine Industry Excellence Award 2Encorium Named as Finalist for the Second Annual Vaccine Industry Excellence Award 3Encorium Named as Finalist for the Second Annual Vaccine Industry Excellence Award 4
(Date:12/3/2009)... Now in its 32nd year, the CTRC-AACR San ... in breast cancer science and world leaders from industry ... , This year, more than 8,500 scientists and ... Convention Center in San Antonio from Dec. 9-13, 2009. ...
(Date:12/3/2009)... must be included in the design of the upcoming forest ... according to a scientist at the University of Leeds. ... argues that at least 50% of the carbon credit payments ... from Deforestation and Degredation), should be made to forest dwellers ...
(Date:12/2/2009)... cigarette smoke have an increased risk of developing lung cancer ... of this study are published in Cancer Epidemiology, Biomarkers ... Cancer Research, as part of a special tobacco focus in ... 219,000 Americans will be diagnosed with lung cancer; more than ...
Breaking Biology News(10 mins):CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Cystic Fibrosis Foundation Receives Second 4 Star Rating from Charity Navigator for Exceptional Fiscal Management 54308 1Cystic Fibrosis Foundation Receives Second 4 Star Rating from Charity Navigator for Exceptional Fiscal Management 54308 2New Audio Podcast Provides an Insider 26apos 3Bs View of the Healthcare System 54307 1New Audio Podcast Provides an Insider 26apos 3Bs View of the Healthcare System 54307 2New Audio Podcast Provides an Insider 26apos 3Bs View of the Healthcare System 54307 3Fountain Healthy Aging Inc Announces 245 000 000 Equity Line Of Credit Investment Secured 54304 1Fountain Healthy Aging Inc Announces 245 000 000 Equity Line Of Credit Investment Secured 54304 2Fountain Healthy Aging Inc Announces 245 000 000 Equity Line Of Credit Investment Secured 54304 3
... announced Quebec's first successful combined heart/liver transplant. The patient, ... Institut de cardiologie de Quebec (l'hôpital Laval) to the ... during a 6-hour operation on April 14, 2006 and ... 15 physicians, surgeons and other health care professionals. The ...
... new machine ?the only one of its kind in Australia ... babies. , Scientists at the Monash Institute of Medical Research ... blood pressure and the amount of oxygen in a preterm ... pressure, which reduces the oxygen supply to their brain," said ...
... particularly prone to global warming caused by industrial and ... Now, a University of Utah study finds a surprising ... Arctic's well-known haze ?made of particulate pollution from mid-latitude ... to trap heat. , The effect makes the Arctic ...
Other Biology News:MUHC announces a transplant first in Quebec 2Research offers new hope for preterm babies 2Pollutant haze heats the Arctic 2Pollutant haze heats the Arctic 3Pollutant haze heats the Arctic 4
... Standard Bio for vacuum concentrator/centrifugal evaporator ... biology and biochemistry for rapid and safe ... can be expanded with pumps, different of ... rotors (eliminating sample loss by transfer), ensuring ...
...
... Start up kit. Includes configured Laptop PC ... 1 MultiBlock satellite thermal Cycler (non-robotic). ... User friendly software. Store/track run data. ... lid. Outstanding uniformity. Advanced control ...
For relative and/or absolute quantification with standard accuracy requirements using MS or NMR instruments...
Biology Products: